Clinical Trial: Corneal Thinning During Topical Bevacizumab Therapy

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.

Detailed Summary:
Sponsor: Yonsei University

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Yonsei University

Dates:
Date Received: August 13, 2007
Date Started: May 2007
Date Completion:
Last Updated: April 29, 2015
Last Verified: April 2015